Assertio Therapeutics, Inc.

( )
ASRT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
ABBVAbbVie, Inc. 2.34%93.021.9%$1186.74m
BMYBristol-Myers Squibb Co. 1.11%60.881.0%$1017.89m
JNJJohnson & Johnson -1.29%146.730.7%$981.40m
PFEPfizer Inc. -0.43%36.010.9%$952.53m
MRKMerck & Co., Inc. -0.62%81.550.7%$859.75m
LLYEli Lilly & Co. -1.19%150.711.1%$518.38m
AZNAstraZeneca Plc -2.04%53.881.2%$285.14m
NVSNovartis AG -0.69%85.110.2%$148.55m
GSKGlaxoSmithKline Plc -1.12%41.650.2%$128.42m
NVONovo Nordisk A/S -0.57%64.340.1%$86.12m
SNYSanofi 0.75%49.950.2%$77.97m
RGENRepligen Corp. -4.19%121.827.1%$69.06m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 1.71%67.410.0%$52.59m
TPTXTurning Point Therapeutics, Inc. -11.41%62.190.0%$36.90m
RETAReata Pharmaceuticals, Inc. -4.35%129.533.4%$36.23m

Company Profile

Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.